Optimapharm has announced the expansion of its office network to New York, USA, and Budapest, Hungary. In addition, Optimapharm has appointed Roy Ovel as chief commercial officer and Charles Denis Maher as vice president Business Development (Americas). Optimapharm is a European CRO with the leading position in Central and Southeast Europe and access to a market of over 300 million people.  At the begining of the year, Optimapharm acquired the leading Czech CRO company MKS Research. Today, O...